Teva Settles Claims Over Delayed Generic Asthma Inhalers
By Julie Manganis · August 5, 2025, 3:17 PM EDT
Teva Pharmaceuticals has settled a 2023 lawsuit by a coalition of union healthcare funds accusing the company of thwarting the introduction of a generic version of its QVAR inhalers to the...
To view the full article, register now.